TWI640319B - Method for preparing fermented juice with anti-inflammation activity - Google Patents

Method for preparing fermented juice with anti-inflammation activity Download PDF

Info

Publication number
TWI640319B
TWI640319B TW106115779A TW106115779A TWI640319B TW I640319 B TWI640319 B TW I640319B TW 106115779 A TW106115779 A TW 106115779A TW 106115779 A TW106115779 A TW 106115779A TW I640319 B TWI640319 B TW I640319B
Authority
TW
Taiwan
Prior art keywords
bcrc
mixture
inflammatory activity
fermentation substrate
preparation
Prior art date
Application number
TW106115779A
Other languages
Chinese (zh)
Other versions
TW201900201A (en
Inventor
陳怡妗
許長祿
駱榮龍
黃水成
詹惠婷
Original Assignee
健茂生物科技股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 健茂生物科技股份有限公司 filed Critical 健茂生物科技股份有限公司
Priority to TW106115779A priority Critical patent/TWI640319B/en
Application granted granted Critical
Publication of TWI640319B publication Critical patent/TWI640319B/en
Publication of TW201900201A publication Critical patent/TW201900201A/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

一種具有抗發炎活性之醱酵液的製備方法,係包含:提供一醱酵基質,包含以重量體積百分比計為2~20%之檸檬皮汁醱酵液、2~15%之葡萄糖胺、2~10%之蘋果汁及2~12%之維他命C,其餘比例為水,該檸檬皮汁醱酵液係以一胚芽乳酸桿菌DSM 32004及一季蒙也有孢漢遜酵母菌DSM 32005共同醱酵一檸檬皮汁所獲得;提供一菌株混合物,包含一鼠李糖乳桿菌BCRC 10940、一雙岐桿菌BCRC 11844及一保加利亞乳桿菌BCRC 10696;及於24~37℃之溫度下,以該菌株混合物共同醱酵該醱酵基質4~9天;據此,可以獲得具有抗發炎活性之醱酵液。 The invention relates to a method for preparing a mashing solution having anti-inflammatory activity, which comprises: providing a fermentation substrate comprising 2 to 20% by weight of a lemon peel juice broth, 2 to 15% glucosamine, 2 ~10% apple juice and 2-12% vitamin C, the remaining proportion is water, the lemon peel juice broth is a yeast one with Lactobacillus sp. DSM 32004 and one season with Hansenella spp. DSM 32005 Provided by lemon peel juice; providing a mixture of strains comprising Lactobacillus rhamnosus BCRC 10940, Bifidobacterium BCRC 11844 and Lactobacillus bulgaricus BCRC 10696; and at a temperature of 24-37 ° C, a mixture of the strains The fermentation substrate is fermented for 4 to 9 days; accordingly, a fermentation broth having anti-inflammatory activity can be obtained.

Description

具有抗發炎活性之醱酵液的製備方法 Method for preparing mash fermentation liquid with anti-inflammatory activity

本發明係關於一種醱酵液的製備方法,特別關於一種製得具有抗發炎活性之醱酵液的製備方法。 The present invention relates to a method for preparing a mashing solution, and more particularly to a method for preparing a mashing solution having anti-inflammatory activity.

中國公開第104970405A號專利案提供一種檸檬皮汁醱酵液的製備方法,係以一胚芽乳酸桿菌(Lactobacillus plantarum,寄存於德國菌種中心,寄存編號為DSM 32004)及一季蒙也有孢漢遜酵母菌(Hanseniaspora guilliermondii,寄存於德國菌種中心,寄存編號為DSM 32005)共同醱酵一檸檬皮汁所獲得。該檸檬皮汁醱酵液不僅含有高量的檸檬多酚,且具有較佳的適口性,因而可以作為含有檸檬多酚的營養補充品;例如可以混合葡萄糖胺、蘋果汁及維生素C來作為用以供人體補充檸檬多酚、葡萄糖胺等有益成分的習用飲品。 The Chinese Patent Publication No. 104970405A provides a method for preparing a lemon peel juice broth, which is a Lactobacillus plantarum (stored in the German Strain Center, registered as DSM 32004) and a season of Hansenula The bacterium (Hanseniaspora guilliermondii, deposited at the German Center for Strain, deposited under the number DSM 32005) was obtained by fermenting a lemon peel juice. The lemon peel juice broth not only contains high amount of lemon polyphenols, but also has good palatability, so it can be used as a nutritional supplement containing lemon polyphenols; for example, glucosamine, apple juice and vitamin C can be mixed It is a customary drink for the human body to supplement beneficial ingredients such as lemon polyphenols and glucosamine.

該習用飲品雖然藉由檸檬多酚、葡萄糖胺及維生素C而具有抗發炎效力,惟若是能夠藉由後續醱酵製程提升其抗發炎活性,確實為提升消費者健康的一大貢獻。 Although the medicinal drink has anti-inflammatory effects by lemon polyphenols, glucosamine and vitamin C, it is indeed a great contribution to the health of consumers if it can enhance its anti-inflammatory activity by the subsequent fermentation process.

本發明係提供一種具有抗發炎活性之醱酵液的製備方法,係藉由醱酵製程獲得具有抗發炎活性之醱酵液者。 The present invention provides a preparation method of a lyophilized solution having anti-inflammatory activity, which is obtained by a fermentation process to obtain a lytic juice having anti-inflammatory activity.

本發明之一種具有抗發炎活性之醱酵液的製備方法,係包含:提供一醱酵基質,包含以重量體積百分比計為2~20%之檸檬皮汁醱酵 液、2~15%之葡萄糖胺、2~10%之蘋果汁及2~12%之維他命C,其餘比例為水,該檸檬皮汁醱酵液係以一胚芽乳酸桿菌DSM 32004及一季蒙也有孢漢遜酵母菌DSM 32005共同醱酵一檸檬皮汁所獲得;提供一菌株混合物,包含一鼠李糖乳桿菌BCRC 10940、一雙岐桿菌BCRC 11844及一保加利亞乳桿菌BCRC 10696;及於24~37℃之溫度下,以該菌株混合物共同醱酵該醱酵基質4~9天;藉由前述具有抗發炎活性之醱酵液的製備方法可以藉由該菌株混合物的共同醱酵,獲得具有較佳抗發炎效力之醱酵液,為本發明之功效。 The preparation method of the lactic acid solution with anti-inflammatory activity of the present invention comprises: providing a fermentation substrate comprising 2 to 20% by weight of a lemon peel juice fermentation Liquid, 2~15% glucosamine, 2~10% apple juice and 2~12% vitamin C, the rest ratio is water, the lemon peel juice broth is a Lactobacillus maltophilia DSM 32004 and a season S. hanseensis DSM 32005 is jointly fermented with lemon peel juice; a mixture of strains is provided, comprising a Lactobacillus rhamnosus BCRC 10940, a double bacillus BCRC 11844 and a Lactobacillus bulgaricus BCRC 10696; and at 24~ The fermentation substrate is further fermented by the mixture of the strain for 4 to 9 days at a temperature of 37 ° C; the preparation method of the lactic acid solution having the anti-inflammatory activity can be obtained by co-fermentation of the mixture of the strains. The anti-inflammatory effect of the fermentation broth is the efficacy of the present invention.

本發明之具有抗發炎活性之醱酵液的製備方法,其中,該具有抗發炎活性之醱酵液的製備方法另包含:混合該醱酵基質及該菌株混合物,使每公升之醱酵基質混合1×106~1×108CFU的菌株混合物,續以該菌株混合物共同醱酵該醱酵基質;藉由適量的菌株混合物之添加,可以提升後續醱酵流程的效率。 The preparation method of the lactic acid solution with anti-inflammatory activity of the present invention, wherein the preparation method of the lactic acid solution having anti-inflammatory activity further comprises: mixing the fermentation substrate and the mixture of the strain to mix the fermentation substrate per liter A mixture of strains of 1×10 6 to 1×10 8 CFU is continuously fermented with the mixture of the strains; the addition of a suitable mixture of strains can increase the efficiency of the subsequent fermentation process.

本發明之具有抗發炎活性之醱酵液的製備方法,其中,該菌株混合物包含以菌量百分比計為:10~46%之鼠李糖乳桿菌BCRC 10940、6~41%之雙岐桿菌BCRC 11844及34~79%之保加利亞乳桿菌BCRC 10696;藉由特定菌種的選用,可以提升後續醱酵流程的效率。 The preparation method of the lactic acid solution with anti-inflammatory activity of the present invention, wherein the mixture of the strain comprises: 10% to 46% of Lactobacillus rhamnosus BCRC 10940, 6 to 41% of Bifidobacterium BCRC 11844 and 34~79% of Lactobacillus bulgaricus BCRC 10696; the efficiency of the subsequent fermentation process can be improved by the selection of specific strains.

本發明之具有抗發炎活性之醱酵液的製備方法,其中,該醱酵基質包含以重量體積百分比計為44.44%之檸檬皮汁醱酵液、27.78%之葡萄糖胺、16.67%之蘋果汁及11.11%之維他命C,該菌株混合物包含以菌量百分比計為:29.41%之鼠李糖乳桿菌BCRC 10940、23.53%之雙岐桿菌BCRC 11844及47.06%之保加利亞乳桿菌BCRC 10696,且係於26℃之溫度下,以該菌株混合物共同醱酵該醱酵基質7天;如此藉由條件的優化,提升所獲得之醱酵液的抗發炎活性。 The preparation method of the anti-inflammatory activity broth of the present invention, wherein the fermentation substrate comprises 44.44% by weight of a lemon peel broth, 27.78% glucosamine, 16.67% apple juice and 11.11% of vitamin C, the mixture of the strain comprises: 29.41% of Lactobacillus rhamnosus BCRC 10940, 23.53% of Bifidobacterium BCRC 11844 and 47.06% of Lactobacillus bulgaricus BCRC 10696, and is 26 The fermentation substrate was co-fermented with the mixture of the strain for 7 days at a temperature of ° C; thus, the anti-inflammatory activity of the obtained fermentation broth was enhanced by optimization of the conditions.

第1圖:各組的抗發炎效力評估結果。 Figure 1: Results of anti-inflammatory efficacy assessment for each group.

為讓本發明之上述及其他目的、特徵及優點能更明顯易懂,下文特舉本發明之較佳實施例,並配合所附圖式,作詳細說明如下:本發明之一實施例的具有抗發炎活性之醱酵液的製備方法係可以包含:提供一醱酵基質及一菌株混合物;及以該菌株混合物共同醱酵該醱酵基質,藉此製得該具有抗發炎活性之醱酵液。 The above and other objects, features and advantages of the present invention will become more <RTIgt; The preparation method of the anti-inflammatory activity broth may include: providing a fermentation substrate and a mixture of the strain; and jointly fermenting the fermentation substrate with the mixture of the strain, thereby preparing the lactic acid solution having anti-inflammatory activity .

詳而言之,該醱酵基質可以為如前述之習用飲品,即包含:以重量體積百分比計為2~20%之檸檬皮汁醱酵液、2~15%之葡萄糖胺、2~10%之蘋果汁及2~12%之維他命C,其餘比例為水;較佳可以包含以重量體積百分比計為16%之檸檬皮汁醱酵液、10%之葡萄糖胺、6%之蘋果汁及4%之維他命C(即每公升之醱酵基質包含160公克之檸檬皮汁醱酵液、100公克之葡萄糖胺、60公克之蘋果汁及40公克之維他命C)。 In detail, the fermented substrate may be a conventional drink as described above, that is, comprising: 2 to 20% by weight of the lemon peel juice, 2 to 15% of glucosamine, 2 to 10% The apple juice and 2~12% of vitamin C, the remaining proportion is water; preferably, it may contain 16% by weight of the lemon peel juice, 10% glucosamine, 6% apple juice and 4 % of vitamin C (ie, each liter of fermented substrate contains 160 grams of lemon peel broth, 100 grams of glucosamine, 60 grams of apple juice, and 40 grams of vitamin C).

接著,可以於該醱酵基質之中加入適量的菌株混合物,該菌株混合物包含一包含一鼠李糖乳桿菌、一雙岐桿菌及一保加利亞乳桿菌,於本實施例中,該鼠李糖乳桿菌、該雙岐桿菌及該保加利亞乳桿菌均係購自中華民國食品工業發展研究所,其編號分別為BCRC 10940、BCRC 11844及BCRC 10696。較佳地,該菌株混合物可以包含以菌量百分比計為:10~46%之鼠李糖乳桿菌(Lactobacillus rhamnosus(Hansen)Collins et al.;BCRC 10940)、6~41%之雙岐桿菌(Bifidobacterium bifidum(Tissier)Orla-Jensen;BCRC 11844)及34~79%之保加利亞乳桿菌(Lactobacillus delbrueckii subsp.Bulgaricus(Orla-Jensen)Weiss et al.;BCRC 10696);於本實施例中,則係包含以菌量百分比計為:29.41%之鼠李糖乳桿菌(BCRC 10940)、23.53%之雙岐桿菌(BCRC 11844)及47.06%之保加利亞乳桿菌 (BCRC 10696)。 Then, an appropriate amount of the strain mixture may be added to the fermentation substrate, the strain mixture comprising a lactobacillus rhamnosus, a double bacillus and a Lactobacillus bulgaricus. In the present embodiment, the rhamnosolic milk Bacillus, the Bifidobacterium and the Lactobacillus bulgaricus were purchased from the Republic of China Food Industry Development Institute under the numbers BCRC 10940, BCRC 11844 and BCRC 10696. Preferably, the strain mixture may comprise, in terms of percentage of bacteria: 10 to 46% of Lactobacillus rhamnosus (Hansen Collins et al.; BCRC 10940), and 6 to 41% of Bifidobacterium (%) Bifidobacterium bifidum (Tissier) Orla-Jensen; BCRC 11844) and 34-79% of Lactobacillus delbrueckii subsp. Bulgaricus (Orla-Jensen) Weiss et al.; BCRC 10696); in this embodiment, Percentage of bacteria: 29.41% of Lactobacillus rhamnosus (BCRC 10940), 23.53% of Bifidobacterium (BCRC 11844) and 47.06% of Lactobacillus bulgaricus (BCRC 10696).

為了提升後續的醱酵效率,於本實施例中,係優先混合該醱酵基質及該菌株混合物,使每公升之醱酵基質混合1×106~1×108CFU的菌株混合物,續於24~37℃之溫度下,以該菌株混合物共同醱酵該醱酵基質4~9天,較佳可以於26℃之溫度下,以該菌株混合物共同醱酵該醱酵基質7天,即可以獲得該具有抗發炎活性之醱酵液。 In order to enhance the subsequent fermentation efficiency, in the present embodiment, the fermentation substrate and the mixture of the mixture are preferentially mixed to mix a mixture of 1×10 6 to 1×10 8 CFU per liter of the fermentation substrate, which is continued. The fermentation substrate is further fermented by the mixture of the strain for 4 to 9 days at a temperature of 24 to 37 ° C, preferably at a temperature of 26 ° C, and the fermentation substrate is simultaneously fermented for 7 days. The lysate having anti-inflammatory activity is obtained.

為證實本發明之醱酵液的製備方法確實能夠製得具有抗發炎活性之醱酵液,遂以脂多糖(lipopolysaccharide,簡稱LPS)誘發老鼠巨噬細胞株(RAW264.7)產生發炎反應,續量測分泌至上清液中的亞硝酸鹽(nitrite)含量以評估抗發炎的效力;本試驗各組老鼠巨噬細胞株的處理條件如第1表所示。 In order to confirm that the preparation method of the mashing liquid of the present invention can produce a lytic solution having anti-inflammatory activity, the inflammatory reaction of the mouse macrophage cell line (RAW264.7) induced by lipopolysaccharide (LPS) continues. The nitrite content secreted into the supernatant was measured to evaluate the anti-inflammatory efficacy; the treatment conditions of the mouse macrophage strains of each group in the test were as shown in Table 1.

1:該醱酵基質包含以重量體積百分比計為16%之檸檬皮汁醱酵液、10%之葡萄糖胺、6%之蘋果汁及4%之維他命C。 1 : The fermentation substrate comprises 16% by weight of a lemon peel broth, 10% glucosamine, 6% apple juice and 4% vitamin C.

2:該醱酵液係為以前述醱酵基質,經該菌株混合物(包含鼠李糖乳桿菌BCRC 10940、雙岐桿菌BCRC 11844及保加利亞乳桿菌BCRC 10696),於26℃之溫度下共同醱酵7天所獲得。 2 : The lysate is fermented at the temperature of 26 ° C by the mixture of the above-mentioned strains (including Lactobacillus rhamnosus BCRC 10940, Bacillus brevis BCRC 11844 and Lactobacillus bulgaricus BCRC 10696) at a temperature of 26 ° C. Obtained in 7 days.

請參照第1圖所示,脂多糖的處理確實會誘發老鼠巨噬細胞株分泌亞硝酸鹽至上清液中,且添加該醱酵基質或本發明之醱酵液均可以 降低亞硝酸鹽的分泌量,其中又以本發明之醱酵液的效果為佳。 Referring to Figure 1, the treatment of lipopolysaccharide does induce the secretion of nitrite from the macrophage cell line into the supernatant, and the addition of the fermentation substrate or the fermentation broth of the present invention can be carried out. The amount of nitrite secretion is lowered, and the effect of the mashing solution of the present invention is preferred.

綜合上述,本發明之具有抗發炎活性之醱酵液的製備方法,係藉由該菌株混合物的共同醱酵,確實能夠獲得具有較佳抗發炎效力之醱酵液,為本發明之功效。 In summary, the preparation method of the lactic acid solution having anti-inflammatory activity of the present invention is capable of obtaining a lysate having better anti-inflammatory effect by co-fermentation of the mixture of the strain, which is an effect of the present invention.

雖然本發明已利用上述較佳實施例揭示,然其並非用以限定本發明,任何熟習此技藝者在不脫離本發明之精神和範圍之內,相對上述實施例進行各種更動與修改仍屬本發明所保護之技術範疇,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 While the invention has been described in connection with the preferred embodiments described above, it is not intended to limit the scope of the invention. The technical scope of the invention is protected, and therefore the scope of the invention is defined by the scope of the appended claims.

Claims (6)

一種具有抗發炎活性之醱酵液的製備方法,係包含:提供一醱酵基質,包含以重量體積百分比計為2~20%之檸檬皮汁醱酵液、2~15%之葡萄糖胺、2~10%之蘋果汁及2~12%之維他命C,其餘比例為水,該檸檬皮汁醱酵液係以一胚芽乳酸桿菌DSM 32004及一季蒙也有孢漢遜酵母菌DSM 32005共同醱酵一檸檬皮汁所獲得;提供一菌株混合物,包含一鼠李糖乳桿菌BCRC 10940、一雙岐桿菌BCRC 11844及一保加利亞乳桿菌BCRC 10696;及於24~37℃之溫度下,以該菌株混合物共同醱酵該醱酵基質4~9天。The invention relates to a method for preparing a mashing solution having anti-inflammatory activity, which comprises: providing a fermentation substrate comprising 2 to 20% by weight of a lemon peel juice broth, 2 to 15% glucosamine, 2 ~10% apple juice and 2-12% vitamin C, the remaining proportion is water, the lemon peel juice broth is a yeast one with Lactobacillus sp. DSM 32004 and one season with Hansenella spp. DSM 32005 Provided by lemon peel juice; providing a mixture of strains comprising Lactobacillus rhamnosus BCRC 10940, Bifidobacterium BCRC 11844 and Lactobacillus bulgaricus BCRC 10696; and at a temperature of 24-37 ° C, a mixture of the strains The yeast substrate is fermented for 4 to 9 days. 如申請專利範圍第1項所述之具有抗發炎活性之醱酵液的製備方法,其中,該醱酵基質包含以重量體積百分比計為16%之檸檬皮汁醱酵液、10%之葡萄糖胺、6%之蘋果汁及4%之維他命C,其餘比例為水。The preparation method of the lactic acid solution having anti-inflammatory activity according to the first aspect of the invention, wherein the fermentation substrate comprises 16% by weight of a lemon peel broth, 10% glucosamine 6% of apple juice and 4% of vitamin C, the rest is water. 如申請專利範圍第1項所述之具有抗發炎活性之醱酵液的製備方法,其中,該具有抗發炎活性之醱酵液的製備方法另包含:混合該醱酵基質及該菌株混合物,使每公升之醱酵基質混合1×106~1×108CFU的菌株混合物,續以該菌株混合物共同醱酵該醱酵基質。The preparation method of the lactic acid solution having anti-inflammatory activity according to the first aspect of the invention, wherein the preparation method of the lactic acid solution having anti-inflammatory activity further comprises: mixing the fermentation substrate and the mixture of the strain to make A mixture of 1 x 10 6 to 1 x 10 8 CFU of the strain was mixed per liter of the fermentation substrate, and the fermentation substrate was further fermented with the mixture of the strains. 如申請專利範圍第1項所述之具有抗發炎活性之醱酵液的製備方法,其中,係於26℃之溫度下,以該菌株混合物共同醱酵該醱酵基質7天。The preparation method of the lactic acid solution having anti-inflammatory activity as described in claim 1, wherein the fermentation substrate is co-fermented with the mixture of the strain for 7 days at a temperature of 26 °C. 如申請專利範圍第1項所述之具有抗發炎活性之醱酵液的製備方法,其中,該菌株混合物包含以菌量百分比計為:10~46%之鼠李糖乳桿菌BCRC 10940、6~41%之雙岐桿菌BCRC 11844及34~79%之保加利亞乳桿菌BCRC 10696。The preparation method of the lactic acid solution having anti-inflammatory activity according to the first aspect of the invention, wherein the mixture of the strain comprises 10% to 46% of Lactobacillus rhamnosus BCRC 10940, 6~ 41% Bifidobacterium BCRC 11844 and 34-79% of Lactobacillus bulgaricus BCRC 10696. 如申請專利範圍第5項所述之具有抗發炎活性之醱酵液的製備方法,其中,該菌株混合物包含以菌量百分比計為:29.41%之鼠李糖乳桿菌BCRC 10940、23.53%之雙岐桿菌BCRC 11844及47.06%之保加利亞乳桿菌BCRC 10696。The preparation method of the lactic acid solution having anti-inflammatory activity according to claim 5, wherein the strain mixture comprises: 29.41% of Lactobacillus rhamnosus BCRC 10940, 23.53% in terms of percentage of bacteria. Bacillus licheniformis BCRC 11844 and 47.06% of Lactobacillus bulgaricus BCRC 10696.
TW106115779A 2017-05-12 2017-05-12 Method for preparing fermented juice with anti-inflammation activity TWI640319B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW106115779A TWI640319B (en) 2017-05-12 2017-05-12 Method for preparing fermented juice with anti-inflammation activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW106115779A TWI640319B (en) 2017-05-12 2017-05-12 Method for preparing fermented juice with anti-inflammation activity

Publications (2)

Publication Number Publication Date
TWI640319B true TWI640319B (en) 2018-11-11
TW201900201A TW201900201A (en) 2019-01-01

Family

ID=65034089

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106115779A TWI640319B (en) 2017-05-12 2017-05-12 Method for preparing fermented juice with anti-inflammation activity

Country Status (1)

Country Link
TW (1) TWI640319B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115553462A (en) * 2021-06-30 2023-01-03 健茂生物科技股份有限公司 Compound composition for relieving alcoholism

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1250232C (en) * 2001-02-06 2006-04-12 雀巢制品公司 Endotoxin binding by lactic acid bacteria and bifidobacteria
CN102907726B (en) * 2012-10-09 2015-02-11 广东盆地一号生物产业有限公司 Natural lemon enzyme beverage and preparation method and application thereof
CN104970405A (en) * 2014-02-21 2015-10-14 东莞健茂生物科技有限公司 A lemon fermentation method to enhance lemon polyphenol contents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1250232C (en) * 2001-02-06 2006-04-12 雀巢制品公司 Endotoxin binding by lactic acid bacteria and bifidobacteria
CN102907726B (en) * 2012-10-09 2015-02-11 广东盆地一号生物产业有限公司 Natural lemon enzyme beverage and preparation method and application thereof
CN104970405A (en) * 2014-02-21 2015-10-14 东莞健茂生物科技有限公司 A lemon fermentation method to enhance lemon polyphenol contents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115553462A (en) * 2021-06-30 2023-01-03 健茂生物科技股份有限公司 Compound composition for relieving alcoholism

Also Published As

Publication number Publication date
TW201900201A (en) 2019-01-01

Similar Documents

Publication Publication Date Title
Enujiugha et al. Probiotic potentials of cereal-based beverages
CN101160389B (en) Novel acid tolerant lactobacillus sakei probio- 65 with the ability of growth suppression of pathogenic microorganisms and the anti-allergic effect
Todorov et al. Traditional cereal fermented foods as sources of functional microorganisms
CN104342340B (en) A kind of preparation method of fermentative brown rice biodiasmin drink
Oluwajoba et al. In vitro screening and selection of probiotic lactic acid bacteria isolated from spontaneously fermenting kunu-zaki
Gustaw et al. New insight into bacterial interaction with the matrix of plant-based fermented foods
Petrova et al. Antimicrobial activity of starch-degrading Lactobacillus strains isolated from boza
CN104630099A (en) Bifidobacterium longum strain and application thereof in preparing active Bifidobacterium fermented beverage
Ali et al. Use of starter cultures of lactic acid bacteria and yeasts in the preparation of kisra, a Sudanese fermented food
Calumba et al. Ale beer containing free and immobilized Lactobacillus brevis, a potential delivery system for probiotics
TWI640319B (en) Method for preparing fermented juice with anti-inflammation activity
von Mollendorff et al. Boza, a traditional cereal-based fermented beverage: a rich source of probiotics and bacteriocin-producing lactic acid bacteria
CN109068675A (en) The manufacture of cereal-based lactic acid fermented prod
EP3092320B1 (en) New strains of the genus lactobacillus and use thereof
Mahmoudi Effect of Mentha longifolia L. Essential oil on physicochemical properties of the bio-ayran
Valenzuela et al. Inhibition of food poisoning and pathogenic bacteria by Lactobacillus plantarum strain 2.9 isolated from ben saalga, both in a culture medium and in food
CN103952345B (en) Probiotic preparation containing Lactobacillus casei and Bacillus licheniformis and preparation method thereof
US12075808B2 (en) Production method to increase bioavailability of sugars from natural complex polysaccharides for human, animal and agricultural purposes
TW201902363A (en) Use a mixture of three strains of lactic acid bacteria to improve the dissolved oxygen in the aquaculture pond
KR101757223B1 (en) Method for preparing fermented citrus composition with improved bioactivity
CA2383021C (en) Cereal .beta. glucan - probiotic compositions
Oyedoh et al. Antagonistic Effects of Lactobacillus Isolates Against Diarrhogenic Escherichia coli
Lijuan et al. Optimization of fermentation process of papaya sauerkraut using response surface method
KR101405493B1 (en) The manufacturing method of red ginseng extract by utilizing 3 kinds of human-derived lactic acid bacteria
KR101427830B1 (en) Manufacturing metond of yogurt added probiotics lactic acid bacterial